RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers
Imaging Technology
SEPTEMBER 20, 2023
We are excited, in collaboration with 3BP and others, to advance this molecule through clinical testing to commercialization.” milla1cf Wed, 09/20/2023 - 09:56 September 20, 2023 — RefleXion Medical , Inc., Our partnership with 3BP is as unprecedented in the external-beam radiotherapy industry as our SCINTIX therapy is for cancer treatment.
Let's personalize your content